What's inside this report?

• This report is an essential source for in-depth information and data relating to Country "Sector" industry . It also offers detailed and comprehensive coverage of industry revenue, volume, distribution and industry player share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the "Sector"in Country.

Scope of the Research

• The report provides segment information broken down into detailed categories and sectors in the region.
• Total revenues, products sold, end users, and average pricing.
• Industry shares of all the key competitors.
• Key pipeline products that are set to shape the industry , broken down by segment .
• Information on the top medical equipment industry players in the segment in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, Research and Development projects , corporate growths and contractions and regulation modifications .
• Key M&A deals , partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the market at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the industry in the country.
• Identify growth sectors and opportunities in each market segment within the country.
• Evaluate the pipeline of key products that will change the segment , and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the industry in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the industry in the country.
• Identify and analyze the strengths and weaknesses of the market incumbents in the country.

Table Of Contents

Sector in Country Report
Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 15
2 Country March ket March ket 20
2.1 Introduction 20
2.2 Definitions 20
2.2.1 March ket 20
2.2.2 Category 1 20
2.2.3 Category 2 21
2.2.4 Category 3 22
2.2.5 Category 4 22
2.2.6 Category 5 22
2.2.7 Category 6 22
2.2.8 Category 7 23
3 Country Healthcare Segment Review 24
3.1 Healthcare Expenditure in Country 24
3.2 Healthcare Infrastructure in Country 26
3.2.1 Healthcare Personnel Data in Country 27
3.2.2 Healthcare Facilities Data in Country 28
3.3 Healthcare Policy in Country 29
4 Country and Global March ket March ket Review 30
5 Country March ket March ket 34
5.1 March ket Overview 34
5.2 March ket Segmentation 34
5.3 March ket in Country - March ket Size and Share Analysis (2000 - 2011) 35
5.3.1 March ket in Country, Overall Revenues (2000 - 2011) 35
5.3.2 March ket in Country, Firms Share (2005 - 2006) 37
5.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 38
5.4.1 March ket Drivers 38
5.4.2 March ket Restraints 38
5.4.3 Future Outlook 38
5.5 March ket in Country, March ket Portfolio Analysis 39
6 Country Category 1 March ket 41
6.1 March ket Overview 41
6.2 Application Overview 41
6.3 Category 1 in Country, March ket Size and Share Analysis (2000 - 2011) 42
6.3.1 Category 1 in Country, Overall Revenues (2000 - 2011) 42
6.3.2 Category 1 in Country, Overall Volumes (2000 - 2011) 48
6.3.3 Category 1 in Country, Distribution Share (2005 - 2006) 51
6.3.4 Category 1 in Country, Firms Share (2005 - 2006) 52
6.3.5 Category 1 in Country, Category Revenues (2000 - 2011) 53
6.4 Key March ket Dynamics, Drivers, Restraints and Future Outlook 81
6.4.1 March ket Drivers 81
6.4.2 March ket Restraints 81
6.4.3 Future Outlook 81
6.5 Category 1 in Country, March ket Portfolio Analysis 82
7 Country Category 2 March ket 84
7.1 March ket Overview 84
7.2 Application Overview 84
7.3 Category 2 in Country, March ket Size and Share Analysis (2000 - 2011) 85
7.3.1 Category 2 in Country, Overall Revenues (2000 - 2011) 85
7.3.2 Category 2 in Country, Overall Volumes (2000 - 2011) 89
7.3.3 Category 2 in Country, Distribution Share (2005 - 2006) 91
7.3.4 Category 2 in Country, Firms Share (2005 - 2006) 92
7.3.5 Category 2 in Country, Category Revenues (2000 - 2011) 93
7.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 97
7.4.1 March ket Drivers 97
7.4.2 March ket Restraints 97
7.4.3 Future Outlook 97
8 Country Category 3 March ket 98
8.1 March ket Overview 98
8.2 Application Overview 98
8.3 Category 3 in Country, March ket Size and Share Analysis (2000 - 2011) 99
8.3.1 Category 3 in Country, Overall Revenues (2000 - 2011) 99
8.3.2 Category 3 in Country, Overall Volume (2000 - 2011) 103
8.3.3 Category 3 in Country, Distribution Share (2005 - 2006) 106
8.3.4 Category 3 in Country, Firms Share (2005 - 2006) 107
8.3.5 Category 3 in Country, Category Revenues (2000 - 2011) 108
8.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 124
8.4.1 March ket Drivers 124
8.4.2 March ket Restraints 124
8.4.3 Future Outlook 124
8.5 Category 3 in Country, March ket Portfolio Analysis 125
9 Country Category 4 March ket 127
9.1 March ket Overview 127
9.2 Application Overview 127
9.3 Category 4 in Country, March ket Size and Share Analysis (2000 - 2011) 128
9.3.1 Category 4 in Country, Overall Revenues (2000 - 2011) 128
9.3.2 Category 4 in Country, Overall Volume (2000 - 2011) 132
9.3.3 Category 4 in Country, Distribution Share (2005 - 2006) 134
9.3.4 Category 4 in Country, Firms Share (2005 - 2006) 135
9.3.5 Category 4 in Country, Category Revenues (2000 - 2011) 136
9.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 144
9.4.1 March ket Drivers 144
9.4.2 March ket Restraints 144
9.4.3 Future Outlook 144
9.5 Category 4 in Country, March ket Portfolio Analysis 145
10 Country Category 5 March ket 147
10.1 March ket Overview 147
10.2 Application Overview 147
10.3 Category 5 in Country, March ket Size and Share Analysis (2000 - 2011) 148
10.3.1 Category 5 in Country, Overall Revenues (2000 - 2011) 148
10.3.2 Category 5 in Country, Overall Volume (2000 - 2011) 152
10.3.3 Category 5 in Country, Distribution Share (2005 - 2006) 154
10.3.4 Category 5 in Country, Firms Share (2005 - 2006) 155
10.3.5 Category 5 in Country, Category Revenues (2000 - 2011) 156
10.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 168
10.4.1 March ket Drivers 168
10.4.2 March ket Restraints 168
10.4.3 Future Outlook 168
10.5 Category 5 in Country, March ket Portfolio Analysis 169
11 Country Category 6 March ket 171
11.1 March ket Overview 171
11.2 Application Overview 171
11.3 Category 6 in Country, Firms Share and Size Analysis 172
11.3.1 Category 6 in Country, Overall Revenues (2000 - 2011) 172
11.3.2 Category 6 in Country, Overall Volume (2000 - 2011) 176
11.3.3 Category 6 in Country, Distribution Share (2005 - 2006) 178
11.3.4 Category 6 in Country, Firms Share (2005 - 2006) 179
11.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 180
11.4.1 March ket Drivers 180
11.4.2 March ket Restraints 180
11.4.3 Future Outlook 180
12 Country Category 7 March ket 181
12.1 March ket Overview 181
12.2 Application Overview 181
12.3 Category 7 in Country, March ket Size and Share Analysis (2000 - 2011) 182
12.3.1 Category 7 in Country, Overall Revenues (2000 - 2011) 182
12.3.2 Category 7 in Country, Overall Volume (2000 - 2011) 186
12.3.3 Category 7 in Country, Distribution Share (2005 - 2006) 188
12.3.4 Category 7 in Country, Firms Share (2005 - 2006) 189
12.3.5 Category 7 in Country, Category Revenues (2000 - 2011) 190
12.4 Key March ket Dynamics - Drivers, Restraints and Future Outlook 198
12.4.1 March ket Drivers 198
12.4.2 Restraints 198
12.4.3 Future Outlook 198
12.5 Category 7 in Country, March ket Portfolio Analysis 199
13 Regulation System 201
13.1 Medical Equipment Approval 201
13.2 Central Drugs Authority of Country 202
13.3 Medical Device Regulatory Authority of Country 202
13.4 Classification of medical devices 202
13.4.1 Registration Period 203
13.5 Pricing and Reimbursement 203
14 Distribution Structure 204
15 Overview of Key Firms 205
15.1 Firms 1 205
15.1.1 Firms 1Company Overview 205
15.1.2 Firms 1Business Overview 205
15.1.3 Firms 1Financial Overview 218
15.1.4 Firms 1SWOT Analysis 220
15.1.5 Firms 1Value Chain Analysis 224
15.1.6 Firms 1Portfolio Analysis 227
15.2 Firms 2 229
15.2.1 Firms 2 SWOT 229
15.2.2 Firms 2 Portfolio Analysis 231
15.3 Firms 3 233
15.3.1 Firms 3 Corporate Presentation 233
15.3.2 Firms 3 Business Description 233
15.3.3 Firms 3 Financial Overview 243
15.3.4 Firms 3 SWOT 245
15.3.5 Firms 3 Value Chain Analysis 249
15.3.6 Firms 3 Portfolio Analysis 251
15.4 Firms 4 253
15.4.1 Firms 4 Corporate Presentation 253
15.4.2 Firms 4 Financial Overview 269
15.4.3 Firms 4 SWOT 270
15.4.4 Firms 4 Value Chain Analysis 275
15.4.5 Firms 4 Portfolio Analysis 277
15.5 Firms 5 279
15.5.1 Firms 5 Corporate Presentation 279
15.5.2 Firms 5 Business Description 279
15.5.3 Firms 5 Financial Overview 288
15.5.4 Firms 5 SWOT 290
15.5.5 Firms 5 Value Chain Analysis 294
15.5.6 Firms 5 Portfolio Analysis 296
15.6 Firms 6 298
15.6.1 Firms 6 Corporate Presentation 298
15.6.2 Firms 6 Business Description 298
15.6.3 Firms 6 Financial Overview 311
15.6.4 Firms 6 SWOT 313
15.6.5 Firms 6 Value Chain Analysis 317
15.6.6 Firms 6 Portfolio Analysis 321
15.7 Firms 7 323
15.7.1 Firms 7 Corporate Presentation 323
15.7.2 Firms 7 Business Description 323
15.7.3 Firms 7 Financial Overview 333
15.7.4 Firms 7 SWOT 335
15.7.5 Firms 7 Value Chain Analysis 339
15.7.6 Firms 7 Portfolio Analysis 342
15.8 Firms 8 344
15.8.1 Firms 8 Overview 344
15.8.2 Firms 8 Business Description 344
15.8.3 Firms 8 Financial Overview 350
15.8.4 Firms 8 SWOT 352
15.8.5 Firms 8 Value Chain Analysis 357
15.9 Firms 9 360
15.9.1 Firms 9 Corporate Presentation 360
15.9.2 Firms 9 Business Description 360
15.9.3 Firms 9 SWOT 367
15.9.4 Firms 9 Financial Overview 371
15.9.5 Firms 9 Value Chain Analysis 373
15.10 Firms 10 378
15.10.1 Firms 10 Corporate Presentation 378
15.10.2 Firms 10 Business Description 378
15.11 Firms 11 383
15.11.1 Firms 11 Corporate Presentation 383
15.11.2 Firms 11 Business Description 384
15.11.3 Firms 11 Financial Overview 395
15.11.4 Firms 11 SWOT 397
15.11.5 Firms 11 Value Chain Analysis 401
16 Country March ket News 416
16.1 News 1 416
16.2 News 2 416
16.3 News 3 416
16.4 News 4 416
17 Pipeline Products for Key March ket Firms 418
17.1 Firms 1 Pipeline Products 418
17.1.1 Product 1 418
17.1.2 Product 2 420
17.1.3 Product 3 421
17.1.4 Product 4 422
17.2 Firms 2 Pipeline Products 424
17.2.1 Product 1 424
17.2.2 Product 2 425
17.3 Firms 3 Pipeline Products 427
17.3.1 Product 1 427
17.3.2 Product 2 427
17.3.3 Product 3 428
18 Appendix 430
18.1 Methodology 430
18.1.1 Coverage 430
18.1.2 Secondary Research 430
18.1.3 Primary Research 431
18.1.4 Models 431
18.1.5 Projections 432
18.1.6 Expert Panels 432
18.2 Currency Conversion 433

Note: Some content types may not be available in this report

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 800
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of majo ...

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.